NewsBenzingaAcurx Pharmaceuticals 表示，首位患者已入组新的 PATHFINDER 临床试验，该试验面向多次复发性艰难梭菌感染患者 Acurx Pharmaceuticals 表示，首位患者已入组新的 PATHFINDER 临床试验，该试验面向多次复发性艰难梭菌感染患者 Benzinga 2026.09.29 12:07 (GMT+0) Open on Benzinga Other news TD Cowen Maintains Buy on Kinder Morgan, Raises Price Target to $40 FDA Lifts Three-Year Freeze On Arbutus Biopharma's Hepatitis B Study Dover Q3 2026 Earnings Call Transcript JP Morgan Maintains Overweight on Murphy USA, Lowers Price Target to $626 TD Cowen Maintains Hold on Valero Energy, Raises Price Target to $400 Comcast Calls Rival Broadband Pricing 'Irrational' As Competition Heats Up
